CIA
AGIO icon

Capital Impact Advisors’s Agios Pharmaceuticals AGIO Stock Holding History

Capital Impact Advisors’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-2,835
Closed -$200K – 254
2015
Q3 		$200K Hold
2,835
– – 0.1% 239
2015
Q2 		$315K Hold
2,835
– – 0.14% 231
2015
Q1 		$267K Sell
2,835
-984
-26% -$110K 0.12% 249
2014
Q4 		$428K Hold
3,819
– – 0.2% 82
2014
Q3 		$234 Hold
3,819
– – ﹤0.01% 92
2014
Q2 		$175K Buy
+3,819
New +$156K 0.13% 116

Other funds holding AGIO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
FV2GP
Flagship Ventures 2007 General Partner Cambridge, Massachusetts $107M AUM
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return